| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/28/2008 | CN100390179C Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 05/28/2008 | CN100390178C Polycycloalkylpurines as adenosine receptor antagonists |
| 05/28/2008 | CN100390174C Methylamino-pterin derivative with inhibiting nitric oxide synthetase function |
| 05/28/2008 | CN100390170C 5-(4-(2-(n-methyl-n-(2-pyridil) amino) ethoxy) benzyl) thiazolidine-2, 4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thereof; and its use as pharmaceutical active |
| 05/28/2008 | CN100390160C Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor |
| 05/28/2008 | CN100390158C Novel theterocyclic analogs of diphenylethylene compounds |
| 05/28/2008 | CN100390131C Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 05/28/2008 | CN100389778C Lipase activity inhibitor containing high-molecular weight polyphenol fraction, tea extract and process for producing the same |
| 05/28/2008 | CN100389777C Moderate molecular weighted chondroitin sulfate injection and its preparing process |
| 05/28/2008 | CN100389774C Medicinal composition for treating diabetes and its preparation method |
| 05/28/2008 | CN100389772C Use of zolendronate for mfg. medicament for treatment of bone metabolism diseases |
| 05/27/2008 | US7378529 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/27/2008 | US7378518 Vascular conditions such as atherosclerosis, hypercholesterolemia, diabetes, obesity, stroke, demyelination; lowering plasma levels of sterols and/or stanols |
| 05/27/2008 | US7378500 below the kneecap in a diabetic subject; administering agonist of the non-proteolytically activated thrombin receptor |
| 05/27/2008 | US7378488 for promoting the release of growth hormone and of enhancing wound healing in a human or animal subject; for treating short stature, cachexia, wasting, type 2 diabetes, and poor circulation |
| 05/27/2008 | US7378440 Antidiabetic agents; therapy for insulin resistance |
| 05/27/2008 | US7378437 Use for the diabetes treatment of compounds or salts thereof, having the following general formula (I): A-(B)b0-(C)c0-NO2 wherein A contains the radical of a drug having an antiiflammatory or analgesic activity, B is a bivalen: linking |
| 05/27/2008 | US7378431 Amide derivatives as NMDA receptor antagonists |
| 05/27/2008 | US7378430 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 05/27/2008 | US7378428 phosphodiesterase inhibitors; (Z)-2-(7-bromomethyl-3,3-dimethyl-3,4-dihydro-(2H)-isoquinolin-1-ylidene)-1-(adamantan-1-yl)ethan-1-one; graft versus host disease, osteoporosis, bone fracture, restenosis, arteriosclerosis, obesity, ischemic reperfusion injury, depression, allergies, transplant rejection |
| 05/27/2008 | US7378418 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 05/27/2008 | US7378413 2-amino-3-(alkyl)-pyrimidone derivatives |
| 05/27/2008 | US7378393 Recombinant anticoagulant proteins |
| 05/27/2008 | US7378274 Regulatory nucleic acid for the ABC1 gene, molecules modifying its activity and therapeutic uses |
| 05/27/2008 | US7378117 Method for the production of potato juice products by means of food technology |
| 05/27/2008 | US7378107 administering triglycerides such as triester of caprylic acid or capric acid with glycerin, used along with foods or drugs, without concerning about side effects and restrictive diets |
| 05/22/2008 | WO2008061109A2 Indazole derivatives useful as melanin concentrating receptor ligands |
| 05/22/2008 | WO2008061108A2 Phthalazine derivatives |
| 05/22/2008 | WO2008060476A2 Nitrogen-containing heterocyclic compounds and methods of use thereof |
| 05/22/2008 | WO2008060190A2 Ligands of 5-ht6 receptors, a pharmaceutical composition, method for the production and use thereof |
| 05/22/2008 | WO2008059965A1 Agent for alleviating or preventing stress symptoms and agent for improving mental conditions |
| 05/22/2008 | WO2008059927A1 Collagen peptide composition and food or beverage containing the same |
| 05/22/2008 | WO2008059905A1 Raw material for oral product and oral product using the same |
| 05/22/2008 | WO2008059867A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059866A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059865A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059625A1 Utilization of the function of rare sugar as promoter for the migration of glucokinase from nucleus to cytoplasm |
| 05/22/2008 | WO2008059335A1 Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof |
| 05/22/2008 | WO2008059310A1 Cinnamomum zeylanicum water extracts and their application in diabetes related conditions |
| 05/22/2008 | WO2008059214A1 Bisamlde derivatives and use thereof as fatty acid synthase inhibitors |
| 05/22/2008 | WO2008059207A1 Cannabinoid receptor modulators |
| 05/22/2008 | WO2008059026A1 Novel 2-(2-hydroxyphenyl)benzimidazoles useful for treating obesity and diabetes |
| 05/22/2008 | WO2008059025A1 Novel 2-(2-hydroxyphenyl) benzothiadiazines useful for treating obesity and diabetes |
| 05/22/2008 | WO2008059024A1 2- ( 2 -hydroxyphenyl) -quinazolin-4-ones useful for treating obesity and diabetes |
| 05/22/2008 | WO2008059023A1 New haloalkylsulfone substituted compounds useful for treating obesity and diabetes |
| 05/22/2008 | WO2008058995A2 Use of cytohesin inhibitors for chemically inducing longevity |
| 05/22/2008 | WO2008058967A1 Organic compounds |
| 05/22/2008 | WO2008058461A1 Peg modified exendin or exendin analog and compositions and use thereof |
| 05/22/2008 | WO2008039751A3 2-methylene-(20s,25s)-19,27-dinor-(22e)-vitamin d analogs |
| 05/22/2008 | WO2008038304A3 Therapeutical formulation comprising an alpha-glucosidase inhibitor and a nitric oxide scavenger. |
| 05/22/2008 | WO2007100435A3 Use of dha and ara in the preparation of a composition for the prevention or treatment of anemia |
| 05/22/2008 | US20080120734 Compositions and methods for regulated protein expression in gut |
| 05/22/2008 | US20080119571 Transport proteins; lecithin-cholesterol acyltransferase; for increasing circulating high density lipoprotein cholesterol for treating atherosclerosis and related cardiovascular disorders |
| 05/22/2008 | US20080119561 Methods for preventing or delaying catheter- based resvascularization |
| 05/22/2008 | US20080119553 Preventive and/or therapeutic treatment of hyperlipidemia or non-insulin dependent diabetes mellitus which comprises dministering orally a polyprenyl compound 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid (NIK-333); antidiabetic and -lipemic agents |
| 05/22/2008 | US20080119548 Control Of Feeding Behavior By Changing Neuronal Energy Balance |
| 05/22/2008 | US20080119540 Ingesting daily a compound of tetrahydrolipstatin (Orlistat) for a period of at least two years to prevent weight regain; long-term therapy so as to permanently atrophy the endocrine cells which would otherwise generate more ghrelin; appetite reduction |
| 05/22/2008 | US20080119535 Aminomethyl-4-imidazoles |
| 05/22/2008 | US20080119534 Benzimidazole Derivatives as Therapeutic Agents |
| 05/22/2008 | US20080119525 Pyridoxamine for the Treatment of Diabetic Intermediaries and Post-Amadori Inhibition |
| 05/22/2008 | US20080119516 2-'4(Phenylamino)-Piperidin-1-Yl!-N-Phenyl-Acetamine Derivatives and Related Compounds as Neuropeptide Y5 (NPY5) Ligands for the Treatment of Obesity |
| 05/22/2008 | US20080119512 Carboxamide Derivatives as Therapeutic Agents |
| 05/22/2008 | US20080119488 Modulators Of Nuclear Receptors |
| 05/22/2008 | US20080119487 Novel non-imidazole compounds |
| 05/22/2008 | US20080119484 Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts |
| 05/22/2008 | US20080119466 1-(4-Chloro-3-(trifluoro-methyl)phenyl)-3-(4-imidazo-[4,5-c]pyridin-1-ylphenyl)urea; Raf, a serine-threonine protein kinase inhibitor; Raf/MEK/ERK cascade in proliferation of human cancer cells; anticarcinogenic agent; psoriasis, atherosclerosis, chronic rheumatoid arthritis and diabetes |
| 05/22/2008 | US20080119464 N-(4-piperidin-1-yl-phenyl)-2-[5-(thiaxolidine-3-carbonyl)-pyrrolidin-3-ylidene]-acetamide;antidiabetic agents; hyperglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis |
| 05/22/2008 | US20080119455 {2-[3-(4-Methyl-2-[2-methypropoxy]phenyl)-ureido]-thiazol-4-yl}-acetic acid ethyl ester; glucokinase inhibitor; antidiabetic, hypoglycemic agent; activators of glucokinase |
| 05/22/2008 | US20080119454 Aryl carbonyl derivatives as therapeutic agents |
| 05/22/2008 | US20080119410 comprising administering bactericidal/permeability-increasing protein (BPI proteins) or fragments to a patient suffering from age related macular degeneration (ARMD) |
| 05/22/2008 | US20080119407 Vitamin D Receptor Modulators |
| 05/22/2008 | US20080119404 angiopoietin-related growth factor used as antiobesity agent, an antidiabetic agent, and/or a hypolipidemic agent; polypeptides |
| 05/22/2008 | US20080119402 Compositions and methods for the inhibition of dishevelled proteins |
| 05/22/2008 | US20080119393 Novel exendin agonist compounds |
| 05/22/2008 | US20080118590 Coffee and Zizyphus and/or its plant extract for treating weight reduction, hypertriglyceridemia; dietetics; nutraceuticals |
| 05/22/2008 | US20080118511 PD-L2 Molecules: Novel PD-1 Ligands and Uses Therefor |
| 05/22/2008 | US20080118503 Immunoglobulin specific to leptin receptor/leptin binding protein for use in prevention and treatment of eating, arthritic and autoimmune disorders |
| 05/22/2008 | US20080118498 Appetite hormone specific immunoglobulin for prevention and treatment of eating and weight related disorders |
| 05/22/2008 | US20080118490 Combined use of triglycerides containing medium chain fatty acids and exogenous lipolytic enzymes as feed supplements |
| 05/22/2008 | US20080115559 Method for Operating a Reservoir-Based Sensor Device |
| 05/22/2008 | US20080115361 Protecting chemicals and devices from exposure to environment until usage; covering each individual opening with removable barrier layer; eliminates microvalves; controlled in vivo drug release |
| 05/22/2008 | CA2669884A1 Novel 2-(2-hydroxyphenyl)benzimidazoles useful for treating obesity and diabetes |
| 05/22/2008 | CA2669874A1 Novel 2-(2-hydroxyphenyl) benzothiadiazines useful for treating obesity and diabetes |
| 05/22/2008 | CA2669867A1 2- ( 2 -hydroxyphenyl) -quinazolin-4-ones useful for treating obesity and diabetes |
| 05/22/2008 | CA2669860A1 New haloalkylsulfone substituted compounds useful for treating obesity and diabetes |
| 05/22/2008 | CA2669670A1 Nitrogen-containing heterocyclic compounds and methods of use thereof |
| 05/22/2008 | CA2669607A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | CA2669524A1 Collagen peptide composition and food or beverage containing the same |
| 05/22/2008 | CA2669080A1 Cannabinoid receptor modulators |
| 05/22/2008 | CA2668634A1 Organic compounds |
| 05/22/2008 | CA2668596A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | CA2668592A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | CA2666182A1 Peg modified exendin or exendin analog and compositions and use thereof |
| 05/22/2008 | CA2665698A1 Use of spiro-oxindole compounds as therapeutic agents |
| 05/21/2008 | EP1923390A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 05/21/2008 | EP1923388A1 Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder |
| 05/21/2008 | EP1923067A1 Compositions containing phaseolus vulgaris extract and alpinia officinarum extract for the prevention and treatment of obesity and type II diabetes |
| 05/21/2008 | EP1923066A1 Composition comprising rooibos tea and conjugated linoleic acid (CLA) |
| 05/21/2008 | EP1923065A1 Cholesterol absorption inhibitor |
| 05/21/2008 | EP1923064A2 Use of amine polymer for lowering serum glucose |